Impact of HLA‐DRB1 allele polymorphisms on control of HIV infection in a Peruvian MSM cohort

No abstract is available for this paper.

• Publication year

  2017

• Venue

  HLA

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/tan.13085PMID 28677168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2016

  2016cited by this paper
• Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion

  2016cited by this paper
• The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression

  2015cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations

  2014cited by this paper
• Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control

  2013cited by this paper
• The IMGT/HLA database

  2012cited by this paper
• Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.

  2011cited by this paper
• Association between HLA Class I and Class II Alleles and the Outcome of West Nile Virus Infection: An Exploratory Study

  2011cited by this paper
• The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

  2010cited by this paper
• Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 Infection

  2010cited by this paper
• Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania.

  2010cited by this paper
• Virological, Immune and Host genetics Markers in the Control of HIV Infection

  2009cited by this paper
• HLA genes in Uros from Titikaka Lake, Peru: origin and relationship with other Amerindians and worldwide populations

  2009cited by this paper
• The IMGT/HLA database

  2008cited by this paper
• HLA-B63 Presents HLA-B57/B58-Restricted Cytotoxic T-Lymphocyte Epitopes and Is Associated with Low Human Immunodeficiency Virus Load

  2005cited by this paper
• Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides

  2004cited by this paper
• Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

  2004cited by this paper
• HLA class II diversity in seven Amerindian populations. Clues about the origins of the Aché.

  2003cited by this paper
• A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

  2002cited by this paper
• HLA class I and class II allele distribution in the Peruvian population.

  2000cited by this paper

• Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection

  2025cites this paper
• Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa

  2023cites this paper
• HLA-B*13, B*35 and B*39 Alleles Are Closely Associated With the Lack of Response to ART in HIV Infection: A Cohort Study in a Population of Northern Brazil

  2022cites this paper
• Immunological determinants of clinical outcomes in COVID-19: A quantitative perspective

  2020cites this paper
• Novel Nested Peptide Epitopes Recognized by CD4+ T Cells Induced by HIV-1 Conserved-Region Vaccines

  2020cites this paper
• Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials

  2019cites this paper
• Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1

  2019cites this paper
• HIV T-Cell Vaccines.

  2018cites this paper